Opportunities to address the hepatitis C epidemic in the correctional setting

Clinical Infectious Diseases

Volumn 40, Issue SUPPL. 5, 2005, Pages

  Boutwell, Amy E ^a   Allen, Scott A ^b   Rich, Josiah D ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b STATE OF RHODE ISLAND   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; HEALTH CARE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES;

DELIVERY OF HEALTH CARE; DISEASE OUTBREAKS; GUIDELINES; HEPATITIS C; HIV INFECTIONS; HUMANS; MASS SCREENING; PREVALENCE; PRISONERS; PRISONS; RESEARCH DESIGN; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 16844376498     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427455     Document Type: Conference Paper

References (32)

1. Gilliard DK, Beck AJ. Prison and jail inmates at midyear 1996. National Criminal Justice document 162843. Washington, DC: Bureau of Justice Statistics, 1997.
2. Harrison PM, Karberg JC. Prison and jail inmates at midyear 2002. National Criminal Justice document 198877. Washington, DC: Bureau of Justice Statistics, 2003.
3. The Sentencing Project. Americans behind bars: US and international rates of incarceration, 1995. Washington, DC: The Sentencing Project, 1995. Available at: http://www.sentencingproject.org/pdfs/9030summary.pdf [accessed 9 February 2005].
4. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep 1999; 114:14-29.
5. Mumola CJ. Substance abuse and treatment, state and federal prisoners, 1997. National Criminal Justice document 172871. Washington, DC: Bureau of Justice Statistics, 1999.
6. De Groot AS, Stubblefield E, Bick J. Hepatitis C: a correctional-public health opportunity. Medscape Infect Dis 2001; 3:1-11.
7. Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52(RR-1):1-36 (erratum: MMWR Recomm Rep 2003; 52:205-14).
8. Reindollar RW. Hepatitis C and the correctional population. Am J Med 1999; 107:100S-3S.
9. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92:1789-94.
10. Lauer G, Walker B. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
11. Hagan H, Thiede H, Weiss N, Hopkins S, Duchin J, Alexander E. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001; 91:42-6.
12. Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med 2003; 138:187-90.
13. Glaser JB, Griefinger RB. Correctional health care: a public health opportunity. Ann Intern Med 1993; 118:139-45.
14. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich JD. Hepatitis C in state correctional facilities. Prev Med 1999; 28:92-100.
15. Allen SA, Rich JD, Schwartzaphel B, Friedmann PD. Hepatitis C among offenders - correctional challenge and public health opportunity. Federal Probation 2003; 67:22-7.
16. Wong JB, Koff RS. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C: a cost-effectiveness analysis. Ann Intern Med 2000; 133:665-75.
17. Hammett TM. Making the case for health interventions in correctional facilities. J Urban Health 2001; 78:236-40.
18. American Public Health Association. Standards for health services in correctional institutions. Washington, DC: American Public Health Association, 2003.
19. Anno BJ, Faiver KL, Harness JK. A preliminary model for determining limited for correctional health care services. J Correctional Health Care 1996; 3:67-84.
20. Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am J Public Health 2001; 91:699-700.
21. Zhang T, Li Y, Lai JP, et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003; 38:57-65.
22. Estelle vs. Gamble, 429 US 97 (1976).
23. Crowder C. Jail contractor to treat hepatitis C. Birmingham News, 2 November 2003.
24. Allen SA. Developing a systematic approach to hepatitis C for correctional systems: controversies and emerging consensus. HIV and Hepatitis Education Prison Project. Providence, RI: Brown University, 2003. Available at: http://www.hivcorrections.org/archives/april03/mainarticle.html.
25. Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health 2001; 78:279-89.
26. Kim JY, Rich JD, Zierler S, et al. Successful community follow up and reduced recidivism in HIV positive women prisoners. J Correctional Health Care 1997; 4:5-17.
27. Mitty JA, Stone V, Sands M, et al. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infect Dis 2002; 34:984-90.
28. Associated Press. Study will test potential hepatitis C vaccine on humans. 17 November 2003.
29. US Department of Health and Human Services. Special classes of subjects: protecting human research subjects. In: Penslar RL, ed. Institutional review board guidebook. 2nd ed. Washington, DC: Department of Health and Human Services, 1993. Available at: http://www.hhs.gov/ohrp/irb/irb_chatper6ii.htm#g6 [accessed 9 February 2005].
30. Robillard AG, Gallito-Zaparaniuk P, Arriola KJ, Kennedy S, Hammett T, Braithwaite RL. Partners and processes in HIV services for inmates and ex-offenders: facilitating collaboration and service delivery. Evaluation Review 2003; 27:535-62.
31. Kalambach KC, Lyons PM. Ethical and legal standards for research in prisons. Behav Sci Law 2003; 21:671-86.
32. Moser DJ, Arndt S, Katz JE, et al. Coercion and informed consent in research involving prisoners. Compr Psychiatry 2004; 45:1-9.